98 related articles for article (PubMed ID: 12168069)
1. Tumor dihydropyrimidine dehydrogenase activity in advanced cervical carcinoma.
Nagai N; Shiroyama Y; Oshita T; Mukai K; Shigemasa K; Fujii T; Katsube Y; Matsubayashi S; Murakami T; Ohama K
Oncol Rep; 2002; 9(5):1033-40. PubMed ID: 12168069
[TBL] [Abstract][Full Text] [Related]
2. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
Miyoshi T; Kondo K; Fujino H; Takahashi Y; Sawada N; Sakiyama S; Tsuyuguchi M; Kimura S; Sumitomo M; Monden Y
Anticancer Res; 2005; 25(2A):923-30. PubMed ID: 15868929
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of TS and DPD activities in colorectal carcinoma as a predictive factor of UFT sensitivity].
Funahashi K; Koike J; Saito N; Miki T; Matsumoto H; Ryu M; Shiokawa H; Tokuyama T; Goto T; Teramoto T
Gan To Kagaku Ryoho; 2004 Feb; 31(2):189-93. PubMed ID: 14997749
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
Miyoshi T; Kondo K; Toba H; Yoshida M; Fujino H; Kenzaki K; Sakiyama S; Takehisa M; Tangoku A
Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427
[TBL] [Abstract][Full Text] [Related]
5. [A case of uterine cervical cancer in which UFT was an effective preoperative treatment].
Nagai N; Oshita T; Shigemasa K; Ohama K; Takehara K; Miyaoka S
Gan To Kagaku Ryoho; 1999 Nov; 26(13):2095-9. PubMed ID: 10584579
[TBL] [Abstract][Full Text] [Related]
6. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
Nakagawa T; Tanaka F; Takata T; Matsuoka K; Miyahara R; Otake Y; Yanagihara K; Fukushimab M; Wada H
J Surg Oncol; 2002 Oct; 81(2):87-92. PubMed ID: 12355409
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase.
Nio Y; Iguchi C; Kodama H; Itakura M; Hashimoto K; Koike M; Toga T; Maruyama R; Fukushima M
Oncol Rep; 2007 Jan; 17(1):153-9. PubMed ID: 17143493
[TBL] [Abstract][Full Text] [Related]
9. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Itashiki Y; Harada K; Ferdous T; Yoshida H
Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
[TBL] [Abstract][Full Text] [Related]
10. Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study.
Kawasaki G; Yoshitomi I; Yanamoto S; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Dec; 94(6):717-23. PubMed ID: 12464897
[TBL] [Abstract][Full Text] [Related]
11. [Dihydropyrimidine dehydrogenase activity in urothelial cancer--influence of UFT administration on DPD activity].
Yano A; Hashimoto K; Okuchi T; Mizoguchi H; Mutaguchi K; Nakamoto T; Usui T
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1877-83. PubMed ID: 11729480
[TBL] [Abstract][Full Text] [Related]
12. [Thymidylate synthase and dihydropyrimidine dehydrogenase expression and histological effects of preoperative UFT in gastric cancer patients].
Uyama R; Yoshizawa Y; Tajiri T; Endo Y; Mitsuya T; Sanada Y
Gan To Kagaku Ryoho; 2006 May; 33(5):625-9. PubMed ID: 16685161
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of two fluorouracil administration regimens for colorectal cancer.
Matsusaka S; Yamasaki H; Kitayama Y; Okada T; Maeda S
Oncol Rep; 2003; 10(1):109-13. PubMed ID: 12469154
[TBL] [Abstract][Full Text] [Related]
14. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
Ichikawa W; Uetake H; Shirota Y; Yamada H; Nishi N; Nihei Z; Sugihara K; Hirayama R
Clin Cancer Res; 2003 Feb; 9(2):786-91. PubMed ID: 12576451
[TBL] [Abstract][Full Text] [Related]
15. Dihydropyrimidine dehydrogenase activity during long-term adjuvant treatment with oral uracil and tegafur for colorectal cancer.
Sadahiro S; Suzuki T; Maeda Y; Ishikawa K; Tanaka Y; Yasuda S; Kamijo A; Makuuchi H; Murayama C
Chemotherapy; 2007; 53(6):442-5. PubMed ID: 17952005
[TBL] [Abstract][Full Text] [Related]
16. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
17. Effects of UFT on thymidylate synthase and dihydropyrimidine dehydrogenase activities in lung cancer.
Miyamoto H; Morio A; Izumi H; Yamazaki A; Wang Z; Futagawa T; Sonobe S
Anticancer Res; 2003; 23(5b):4153-6. PubMed ID: 14666617
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
Fukuda H; Takiguchi N; Koda K; Oda K; Seike K; Miyazaki M
Cancer Invest; 2006; 24(3):235-41. PubMed ID: 16809149
[TBL] [Abstract][Full Text] [Related]
19. Enhanced induction of apoptosis in lung adenocarcinoma after preoperative chemotherapy with tegafur and uracil (UFT).
Morio A; Miyamoto H; Izumi H; Futagawa T; Oh T; Yamazaki A; Konno H
Surg Today; 2004; 34(10):822-7. PubMed ID: 15449150
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]